Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: Implications for primary diabetes prevention

Diabetes Care

Volumn 27, Issue 6, 2004, Pages 1439-1446

  Osei, Kwame ^a   Rhinesmith, Scott ^a   Gaillard, Trudy ^a   Schuster, Dara ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CELL FUNCTION; DIABETES CONTROL; FEMALE; FUTUROLOGY; GLUCOSE TRANSPORT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PREDICTION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; BODY SIZE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MIDDLE AGED; OHIO; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; PRIMARY PREVENTION; RISK FACTORS;

EID: 2542501028     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.6.1439     Document Type: Article

References (48)

1. King H, Rewers M: Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 16:157-177, 1993
2. King H, Aubert R, Herman WH: Global burden of diabetes, 1995-2025: prevalence and numerical estimates and projections. Diabetes Care 21:1414-1433, 1998
3. Harris ML, Flegal KM, Cowie C, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer MS, H-M, Byrd-Kolt DID: Prevalence of diabetes, impaired fasting and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Survey 1988-1994. Diabetes Care 21:518-524,1998
4. Harris MI, Klein RD, Cowie CC, Rowland M, Byrd-Holt DD: Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care 21:1230-1235,1998
5. DeFronzo RA: The triumvirate, B-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667-687, 1988
6. Reaven GM, Berstein R, Davis B, Olefsky JM: Nonketotic diabetes mellitus: insulin deficiency or insulin resistance. Am J Med 60:80-88, 1976
7. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secretory dysfunction and, insulin resistance in the pathogenesis of type 2 diabetes. J Clin Invest 104:787-794, 1999
8. DeFronzo RA, Ferrannini E, Simonson DC: Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387-395, 1989
9. Reaven GM, Hollenbeck CB, Chen Y-D: Relationship between glucose tolerance, insulin secretion, and insulin action in obese individuals with varying degrees of glucose tolerance. Diabetologia 32:52-55, 1989
10. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 113:909-915, 1989
11. Tattersal RB, Fajans S: Prevalence of diabetes and glucose intolerance in 199 offspring of 37 conjugal parents. Diabetes 24:452-462, 1975
12. Barrett AH, Eff C, Leslie RDG, Pyke DA: Diabetes in identical twins: a study of 200 pairs. Diabetologia 20:87-93, 1981
13. Martin BC, Warram JH, Ronser B, Rich SS, Soeldner JS, Krowlewski AS: Familial clustering of insulin sensitivity. Diabetes 41:850-854, 1992
14. Martin BC, Warram JH, Krowleski AS, Bergman RW, SoeldnerJS, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a follow-up study. Lancet 340:925-929, 1992
15. O'Rahilly SP, Rudenski AS, Burnett MA, Nugent Z, Hosker JP, Darling P: Beta cell dysfunction rather than insulin sensitivity is the primary defect in familial type 2 diabetes. Lancet 2:3660-3663, 1986
16. Vaag A, Henrikson JE, Madsbad S, Holm N, Beck-Nelson HI: Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for noninsulin dependent mellitus. J Clin Invest 95:690-698, 1995
17. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for noninsulin-dependent diabetes mellitus. N Engl J Med 321:337-343, 1989
18. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, PattersonJK: Increased insulin concentrations in nondiabetic offspring of diabetic patients. N Engl J Med 319:1297-1301, 1986
19. Diabetes Prevention Program Research Group: Reduction in the incident of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:303-403, 2002
20. Tuomillehto J, Lindstrom J, Erickson J, Valle TT, Hamalanien H: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
21. Pan XR, Li G-W, WangJ-X, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in the prevention of NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544, 1997
22. Osei K, Cottrell DA: Minimal model analyses of insulin sensitivity and glucose dependent glucose disposal in black and white Americans: a study of persons at risk for type 2 diabetes. Eur J Clin Invest 24:843-850, 1994
23. Osei K, Schuster DP: Metabolic characteristics of African descendants: a comparative study of African-Americans and Ghanaian immigrants using minimal model analysis. Diabetologia 38:110-119, 1995
24. Osei K, Schuster DP: Ethnic differences in secretion, sensitivity and hepatic extraction of insulin in black and white Americans. Diabet Med 11:755-762, 1994
25. Osei K, Cottrell DA, Harris B: Differences in basal and post-stimulation glucose homeostasis in nondiabetic first-degree relatives of black and white patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 75:82-86,1992
26. Haffner S, Howard R, Saad P, Mayer B, Bergman RN, Savage PJ, Rewers M, Mykkinen L, Karter AJ, Hamman R, Saad ME: Insulin sensitivity and acute insulin responses in African Americans, non-Hispanic whites and Hispanics and NIDDM: the insulin resistance and Atherosclerosis Study. Diabetes 46:63-69, 1997
27. Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykinnen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE, Bergman RN: Increased insulin resistance and insulin secretion in nondiabetic African Americans and Hispanics compared with non-Hispanics compared with non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Diabetes 45: 742-747, 1996
28. Arslanian S, Suprasongsin C: Differences in the in vivo insulin secretion and sensitivity in healthy blacks versus white adolescents. J Pediatr 129:440-443,1996
29. Goran M, Bergman RN, Cruz M, Watanabe R: Insulin resistance and associated compensatory responses in African American and Hispanic children. Diabetes Care 25:2184-2193, 2003
30. Brancati LB, Kao WH, Folsom AB, Watson RL, Szklo M: Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 283:2253-2259,2000
31. Osei K, Gaillard T, Schuster DID: Pathogenetic mechanism of impaired glucose tolerance and type II diabetes in African Americans: the significance of insulin secretion, insulin sensitivity and glucose effectiveness. Diabetes Care 20:396-404, 1997
32. Osei K, Schuster DIP: Decreased insulin-mediated but not non-insulin dependant glucose disposal in glucose intolerance and type 2 diabetes in Africa (Ghanaian) immigrants. Am J Med Sci 311:113-121, 1996
33. Segal KR, Loan MC, Fitzgerald PL, Hodgdon JA, Van Itallie TB: Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr 47:4-17, 1988
34. World Health Organization: Diabetes Mellitus: Report of WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
35. Bergman RN: Toward physiological understanding of glucose tolerance: minimal model approach. Diabetes 336:1512-1527, 1989
36. Bergman RN, Prager R, Volund A, Olefsky J: Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79:790-800, 1987
37. Kahn SE, Prager RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward JC, Palmer JP, Porte D Jr: Quantitation of the relationship between insulin sensitivity and beta cell function in humans: evidence for hyperbolic function. Diabetes 32:1663-1672, 1993
38. Kahn SE, Prager RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward JC, Palmer JP, Porte D Jr: The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes 43:587-592, 1994
39. Mathews DR, Hosker JP, Rudenski as, Taylor BA, Treacher DF, Turner RC: Homeostasis model assessment insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
40. DeFronzo RA, Tobin JD, Andres R: The glucose clamp technique: a method for the quantification of beta cell sensitivity to glucose and of tissue sensitivity to insulin. Am J Physiol 237:E214-E223, 1979
41. Davies MJ, Rayman G, Grentell A, Gray IP, Gray IP, Hales CN: Loss of the first phase response to intravenous glucose in subjects with persistent impaired glucose tolerance. Diabet Med 11:432-436, 1994
42. Lundgren H, Bengtsson C, Bolhme G, Lapidus L, Waldenstom J: Fasting serum 1 insulin concentration and early insulin response as risk determinants for developing diabetes. Diabetes 7:410-413, 1990
43. Best JD, Kahn SE, Ader M, Wantanabe RM, Ta-Ghen N, Bergman RN: Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 19: 1018-1030, 1996
44. Osei K, Cottrell DA, Orabella MM: Insulin sensitivity, glucose effectiveness and body fat distribution patterns in nondiabetic offspring of patients with noninsulin-dependent diabetes mellitus (NIDDM). Diabetes Care 14:890-896, 1991
45. Henriksen JE, Alford F, Humberg A, Vaag A, Henrikson JE, Madsbad S, Holm N, Beck-Nelson HI: Increased glucose effectiveness in normoglycemic but insulin resistant relatives of patients with noninsulin-dependent diabetes mellitus: a novel compensatory mechanism. J Clin Invest 99:1196-1204,1994
46. Osei K: Predicting type II diabetes in persons at risk. Ann Intern Med 113:905-907, 1990
47. Schuster D, Gaillard T, Rhinesmith S, Habash D, Osei K: The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes: a placebo-controlled, 24-month randomized study. Metabolism 52:1211-1217, 2003
48. Buchanan TA: Pancreatic beta cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 86:989-993, 2001